This inventor holds 1 USPTO granted patent. Top assignee: Bioverativ USA Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Christopher Lawrence Vinnard: Innovator in Complement-Mediated Disease Treatment
Introduction
Christopher Lawrence Vinnard is a notable inventor recognized for his contributions to the field of medicine. He has developed innovative methods aimed at treating complement-mediated diseases. His work is significant in advancing therapeutic options for patients suffering from these conditions.
Latest Patents
Christopher holds a patent titled "Methods for Treating Complement-Mediated Diseases." This patent represents his commitment to finding effective solutions in the medical field. He has successfully secured 1 patent that showcases his innovative approach to healthcare.
Career Highlights
Christopher is currently employed at Bioverativ USA Inc., a company dedicated to developing therapies for hemophilia and other rare blood disorders. His role at Bioverativ allows him to apply his expertise in a practical setting, contributing to the advancement of medical treatments.
Collaborations
Throughout his career, Christopher has collaborated with esteemed colleagues, including Miguel Alonso Alonso and Nazem Atassi. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the medical field.
Conclusion
Christopher Lawrence Vinnard is a dedicated inventor whose work in treating complement-mediated diseases has the potential to make a significant impact in medicine. His contributions, along with his collaborations, highlight the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile